News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Alphatec Holdings, Inc. Cuts IPO To $11-$12 Per Share From $13-$15
June 1, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, June 1 (Reuters) - Medical device maker Alphatec Holdings Inc. on Thursday cut the estimated price of its planned initial public offering to between $11 and $12 per share from a previous range of $13 to $15.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
July 27, 2026
·
2 min read
·
Tristan Manalac
IPO
Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech
July 24, 2026
·
3 min read
·
Tristan Manalac
Psychedelics
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
July 24, 2026
·
3 min read
·
Gabrielle Masson
Manufacturing
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
July 22, 2026
·
2 min read
·
Nick Paul Taylor
